MedBioInformatics Solutions are the creators of DISGENET plus. We’re leveraging genetics and AI to support precision medicine.
Human genetics offers the potential to identify new therapeutic targets and prioritize decision-making throughout the process of drug discovery and development.
The commercial offering, DISGENET plus, is a disease genomics platform with the world’s most comprehensive catalog of genes and variants associated with human diseases and phenotypes to unlock the potential of genomics for drug R&D and clinical genomics.

DISGENET plus:
Brings the power of AI and genetics together
Integrates all the information on genes and genomic variants associated with every human disease in a single resource
Based on the community-recognized DisGeNET platform, cited by more than 2500 publications and one of the ELIXIR* Recommended Interoperability Resources.

Coverage of the full spectrum of human diseases as well as normal and abnormal traits, and adverse drug events.
Interoperable resource supporting a variety of applications in genomic medicine and drug R&D.